{{Rsnum
|rsid=3003596
|Gene=NR1I3
|Chromosome=1
|position=161234427
|Orientation=plus
|GMAF=0.4913
|Gene_s=NR1I3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 31.2 | 53.1 | 15.6
| HCB | 23.3 | 46.5 | 30.2
| JPT | 13.6 | 45.5 | 40.9
| YRI | 13.1 | 52.5 | 34.4
| ASW | 0.0 | 0.0 | 0.0
| CHB | 23.3 | 46.5 | 30.2
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23173844
|Title=PXR and CAR single nucleotide polymorphisms influence plasma efavirenz levels in South African HIV/AIDS patients
|OA=1
}}{{PMID Auto
|PMID=18574025
|Title=The largest prospective warfarin-treated cohort supports genetic forecasting.
|OA=1
}}